Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

Among more than 3000 hospitalized patients with Covid-19, recipients of high-titer convalescent plasma had a lower mortality at 30 days than recipients of low-titer plasma. The effect of high-titer plasma was greatest in the subgroup of patients who were not receiving mechanical ventilation.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2021-03, Vol.384 (11), p.1015-1027
Hauptverfasser: Joyner, Michael J, Carter, Rickey E, Senefeld, Jonathon W, Klassen, Stephen A, Mills, John R, Johnson, Patrick W, Theel, Elitza S, Wiggins, Chad C, Bruno, Katelyn A, Klompas, Allan M, Lesser, Elizabeth R, Kunze, Katie L, Sexton, Matthew A, Diaz Soto, Juan C, Baker, Sarah E, Shepherd, John R.A, van Helmond, Noud, Verdun, Nicole C, Marks, Peter, van Buskirk, Camille M, Winters, Jeffrey L, Stubbs, James R, Rea, Robert F, Hodge, David O, Herasevich, Vitaly, Whelan, Emily R, Clayburn, Andrew J, Larson, Kathryn F, Ripoll, Juan G, Andersen, Kylie J, Buras, Matthew R, Vogt, Matthew N.P, Dennis, Joshua J, Regimbal, Riley J, Bauer, Philippe R, Blair, Janis E, Paneth, Nigel S, Fairweather, DeLisa, Wright, R. Scott, Casadevall, Arturo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Among more than 3000 hospitalized patients with Covid-19, recipients of high-titer convalescent plasma had a lower mortality at 30 days than recipients of low-titer plasma. The effect of high-titer plasma was greatest in the subgroup of patients who were not receiving mechanical ventilation.
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMoa2031893